CI News & Events

The Justice Department is expected to charge around 450 defendants for alleged healthcare fraud totaling over $6.5B, The Wall Street Journal's Sabrina Siddiqui and Christopher Weaver reports. The operation spans 57 federal-court districts and 41 states, including 90 medical professionals and over 100 Medicaid fraud defendants, according to the report, which adds that the Justice Department will unveil new data-sharing agreements with the FTC, Homeland Security, and CMS to expand fraud detection. Publicly traded companies in the space include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Humana (HUM), Molina Healthcare (MOH) and UnitedHealth (UNH).

Some employers are considering reducing or eliminating coverage for GLP-1 weight loss drugs next year as usage expands, which may offset some cost benefits from declining prices for therapies like Novo Nordisk's (NVO) Wegovy and Eli Lilly's (LLY) Zepbound, Reuters' Amina Niasse reports. Roughly 10% of employers currently covering GLP-1 weight-loss drugs plan to discontinue that coverage in 2027, according to the Business Group on Health. Cigna (CI) halted coverage of the weight loss treatments for its own employees effective July, Reuters previously reported.